Updated 07:18 GMT, 29 Oct 2026 SPX 7,743.98 +0.28% NDX 29,813.16 +0.55% VIX 16.91 -3.48% GOLD 4,048.10 -0.09% CL 101.44 -1.30% BTC 79,777.91 -1.83%
NAS100 29,813 +0.55% S&P 7,744 +0.28% GOLD $4,048 −0.09% BTC $79,778 −1.83% VIX 16.91 −3.48% latest tape · as of 07:18 UTC
The Screen · Industrials · Engineering & Construction

Stantec Inc. logoStantec Inc.

STN · the NYSE · USD · Market cap $7.7B · 34,000 employees

Stantec Inc.

PASS · Titan Ethical · score 70.0
71.86 USD

Price as of 28 Oct 2026Daily close, not a live quote

Screened 2026-10-28 · the tape above runs as of 07:18 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price71.86 USD at the 28 Oct 2026 close
  • Ethical screenPasses, score 70.0 out of 100
  • OptionsOpen interest leans heavily to calls (put/call 0.22)
  • Last reviewed28 Oct 2026 (1 days ago)

A summary of the dated readings below, not a live quote and not advice.

PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y
73.3380.18122.22

What this means: price 71.86 against the desk's fair-value range, base estimate 80.18, over the last year.

Current read
Markup ?
Screened · screened 2026-10-28
  • Trend Markup
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options put/call open interest 0.22, read 2026-10-28
  • Ethical passes the values gate
Price71.86 USD
Fair value80.18
Ethical score70.0/100
Our investment reviews on this name
2026-10-28Read Markup68.55+4.8% to today ✓Distribution gives way to Markup first Markup read since August
2026-10-02Read Distribution67.14+7.0% to today Markdown gives way to Distribution first Distribution read since July
2026-09-14Read Markdown69.66+3.2% to today Markup gives way to Markdown with volume flow in agreement
2026-08-13Read Markup73.11-1.7% to today Distribution gives way to Markup with results news in the headlines

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markup label.

Stantec Inc. holds its Markup at $71.86. The statistical read favours the sellers, held for 59 days.

As held on the ledger · 2026-10-28
PhaseMarkup
Quantitative stateThe statistical read favours the sellers, held for 59 days
Price at the screen$71.86
Valuation21.42 trailing · 14.02 forward price to earnings
Values screenPASS · score 70.0
Beta0.73
The Workings

Five Screens, Shown in Full

Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 32.01% Below 33% Interest-bearing debt is just 32.0% of its assets, well under the one-third ceiling: it does not run on borrowed money. Pass
Interest-bearing cash 3.50% Below 33% Cash held in interest-bearing accounts and securities is 3.5% of assets, under the one-third limit. Pass
Receivables 20.84% Below 49% Money owed to the company is 20.8% of assets, under the 49% limit. Pass
Revenue purity 0.18% Below 5% Only 0.2% of revenue comes from non-compliant sources, under the 5% line. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Clears, in Plain English

Stantec clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 32%, inside the ~33% line, and almost none of its income is interest, so it passes.

Read as at 2026-10-28. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when STN's ethical verdict changes

Today STN passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

73.33Conservative80.18Base case122.22Growth case 71.86Price

Fair value range in USD, drawn from the 2026-10-28 screen. The gold marker is the market price at the same screen. A 11.6% margin of safety to the base estimate.

Price History & Projections
$110$74$38TODAY5y agoPROJECTIONOur fair value$80.18 +12%Conservative$73.33 +3%

Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-28 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Engineers turning plans into bridges and power grids

Every bridge, office tower or water system starts with someone who can read the local rules, win the permits and keep the project on budget. Stantec does exactly that across Canada, the United States and beyond, serving both governments and private clients in a steady, unglamorous way. Revenue is rising 9 percent, return on equity sits at 15 percent and the shares trade at 14.2 times forward earnings with a 15 percent gap to our fair value.

Those numbers look tidy on paper and the firm clears our ethical screen without issue. Yet the opportunity rating remains none because the business carries the classic traits of engineering and construction work, where earnings can swing with government budgets and economic cycles. Profit margins at 7 percent leave little room for surprises, and the lack of a clear moat means competitors can still win the next tender.

Currency moves, project delays and sudden shifts in public spending remain real threats that the valuation does not fully price in. The shares are not expensive, but they are also not compelling enough to move the rating off neutral. Analysis, not advice.

The fundamentals · plain-English read
Forward P/E14.0xpriced for continued growth
Trailing P/E21.4xa premium valuation
EPS, trailing3.20
EPS, forward4.89
Revenue growth+11.5%steady growth
Profit margin7.4%thin but positive margins
Return on equity15.7%a solid return on shareholder capital
FCF yield8.44%
Dividend yield94.00%
Debt to equity0.81moderate, manageable leverage
Current ratio1.50healthy short-term liquidity
Beta0.73steadier than the market
52-week range65.35 - 114.52
Market cap$7.7B
Employees34,000

The risks · The things to watch: its business and earnings are exposed to Canada and to currency swings.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

STN trades on the NYSE (the company is based in Canada). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-10-28 Markup · changed $68.55 +0.0% Entry 9

The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 14%.

2026-10-21 Distribution $68.55 +2.5% Entry 8

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 2.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 14%.

2026-10-14 Distribution $66.86 -0.4% Entry 7

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 14%.

2026-10-02 Distribution · changed $67.14 -3.6% Entry 6

The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 3.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 14%.

2026-09-14 Markdown · changed $69.66 -4.7% Entry 5

The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 4.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 14%.

2026-08-13 Markup · changed $73.11 +1.2% Entry 4

The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 1.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 14%.

2026-07-18 Distribution $72.26 +0.0% Entry 3

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 14%.

2026-07-03 Distribution $72.26 +0.0% Entry 2

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.

2026-07-02 Distribution $72.26 Entry 1

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on STN

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in STN's Space

Screened names in the same industry · explore each on its own page.

The Political Ledger · Congressional Disclosures
Disclosures naming STN
DatePoliticianPartyTypeAmount
2026-05-06 Dave McCormick Republican sell 100K–250K
What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $85.92 -16.9% · $831 -16.9%
2 months $86.46 -17.4% · $826 -17.4%
3 months $88.67 -19.5% $0.18 $807 -19.3%
6 months $95.07 -24.9% $0.18 $753 -24.7%
1 year $105.14 -32.1% $0.34 $682 -31.8%
2 years $80.04 -10.8% $0.95 $904 -9.6%
3 years $59.82 +19.3% $1.55 $1,219 +21.9%
5 years $43.20 +65.3% $2.63 $1,714 +71.4%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever STN does next, these words stay.

Stantec Inc. · STN · Markup · $71.86
Recorded 2026-10-28 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.